Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults

American Journal of Epidemiology

Volumn 165, Issue 1, 2007, Pages 63-71

  Bluhm, Elizabeth C ^a   Zahm, Shelia Hoar ^a   Fine, Howard A ^a   Black, Peter M ^b   Loeffler, Jay S ^c   Shapiro, William R ^d   Selker, Robert G ^e   Inskip, Peter D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BARROW NEUROLOGICAL INSTITUTE   (United States)

^e WESTERN PENNSYLVANIA HOSPITAL   (United States)

Author keywords

Glioma; Hair dyes; Meningioma; Neuroma, acoustic

Indexed keywords

HAIR DYE;

ADULT; CANCER; DYE; HAIR; RISK FACTOR; TUMOR;

ACOUSTIC NEURINOMA; ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLIOMA; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PREVALENCE; UNITED STATES; URBAN AREA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARIZONA; BEAUTY CULTURE; BOSTON; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; GLIOMA; HAIR DYES; HUMANS; MALE; MENINGIOMA; MIDDLE AGED; NEUROMA, ACOUSTIC; PENNSYLVANIA; RISK ASSESSMENT; RISK FACTORS;

NORTH AMERICA; UNITED STATES;

EID: 33845896556     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwk002     Document Type: Article

References (54)

1. La Vecchia C, Tavani A. Epidemiological evidence on hair dyes and the risk of cancer in humans. Eur J Cancer Prev 1995;4:31-43.
2. Ames BN, Kammen HO, Yamasaki E. Hair dyes are mutagenic: identification of a variety of mutagenic ingredients. Proc Natl Acad Sci U S A 1975;72:2423-7.
3. Searle CE, Jones EL. Effects of repeated applications of two semipermanent hair dyes to the skin of A and DBAf mice. Br J Cancer 1977;36:467-78.
4. Rojanapo W, Kupradinun P, Tepsuwan A, et al. Carcinogenicity of an oxidation product of p-phenylenediamine. Carcinogenesis 1986;7:1997-2002.
5. Gago-Dominguez M, Castelao JE, Yuan JM, et al. Use of permanent hair dyes and bladder-cancer risk. Int J Cancer 2001;91:575-9.
6. Gago-Dominguez M, Bell DA, Watson MA, et al. Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2. Carcinogenesis 2003;24:483-9.
7. Petro-Nustas W, Norton ME, al-Masarweh I. Risk factors for breast cancer in Jordanian women. J Nurs Scholarsh 2002;34:19-25.
8. Zahm SH, Weisenburger DD, Babbitt PA, et al. Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia. Am J Public Health 1992;82:990-7.
9. Cantor KP, Blair A, Everett G, et al. Hair dye use and risk of leukemia and lymphoma. Am J Public Health 1988;78:570-1.
10. Zhang Y, Holford TR, Leaderer B, et al. Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut. Am J Epidemiol 2004;159:148-54.
11. Brown LM, Everett GD, Burmeister LF, et al. Hair dye use and multiple myeloma in white men. Am J Public Health 1992;82:1673-4.
12. Ohno Y, Aoki K, Obata K, et al. Case-control study of urinary bladder cancer in metropolitan Nagoya. Natl Cancer Inst Monogr 1985;69:229-34.
13. Holly EA, Lele C, Bracci PM. Hair-color products and risk for non-Hodgkin's lymphoma: a population-based study in the San Francisco Bay Area. Am J Public Health 1998;88:1767-73.
14. Koenig KL, Pasternack BS, Shore RE, et al. Hair dye use and breast cancer: a case-control study among screening participants. Am J Epidemiol 1991;133:985-95.
15. Mele A, Szklo M, Visani G, et al. Hair dye use and other risk factors for leukemia and pre-leukemia: a case-control study. Italian Leukemia Study Group. Am J Epidemiol 1994;139:609-19.
16. Cote TR, Dosemeci M, Rothman N, et al. Non-Hodgkin's lymphoma and occupational exposure to hair dyes among people with AIDS. Am J Public Health 1993;83:598-9.
17. Tavani A, Negri E, Franceschi S, et al. Hair dye use and risk of lymphoid neoplasms and soft tissue sarcomas. Int J Cancer 2005;113:629-31.
18. Nasca PC, Baptiste MS, Field NA, et al. An epidemiologic case-control study of breast cancer and exposure to hair dyes. Ann Epidemiol 1992;2:577-86.
19. Zheng T, Holford TR, Mayne ST, et al. Use of hair colouring products and breast cancer risk: a case-control study in Connecticut. Eur J Cancer 2002;38:1647-52.
20. Cook LS, Malone KE, Daling JR, et al. Hair product use and the risk of breast cancer in young women. Cancer Causes Control 1999;10:551-9.
21. Nasca PC, Lawrence CE, Greenwald P, et al. Relationship of hair dye use, benign breast disease, and breast cancer. J Natl Cancer Inst 1980;64:23-8.
22. Grodstein F, Hennekens CH, Colditz GA, et al. A prospective study of permanent hair dye use and hematopoietic cancer. J Natl Cancer Inst 1994;86:1466-70.
23. Hennekens CH, Speizer FE, Rosner B, et al. Use of permanent hair dyes and cancer among registered nurses. Lancet 1979;1:1390-3.
24. Altekruse SF, Henley SJ, Thun MJ. Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States). Cancer Causes Control 1999;10:617-25.
25. Thun MJ, Altekruse SF, Namboodiri MM, et al. Hair dye use and risk of fatal cancers in U.S. women. J Natl Cancer Inst 1994;86:210-15.
26. Henley SJ, Thun MJ. Use of permanent hair dyes and bladder-cancer risk. Int J Cancer 2001;94:903-6.
27. Takkouche B, Etminan M, Montes-Martinez A. Personal use of hair dyes and risk of cancer: a meta-analysis. JAMA 2005;293:2516-25.
28. Ahlbom A, Navier IL, Norell S, et al. Nonoccupational risk indicators for astrocytomas in adults. Am J Epidemiol 1986;124:334-7.
29. Burch JD, Craib KJ, Choi BC, et al. An exploratory case-control study of brain tumors in adults. J Natl Cancer Inst 1987;78:601-9.
30. Heineman EF, Ward MH, McComb RD, et al. Hair dyes and risk of glioma among Nebraska women. Cancer Causes Control 2005;16:857-64.
31. Czene K, Tiikkaja S, Hemminki K. Cancer risks in hairdressers: assessment of carcinogenicity of hair dyes and gels. Int J Cancer 2003;105:108-12.
32. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Occupational exposures of hairdressers and barbers and personal use of hair colourants; some hair dyes, cosmetic colourants, industrial dyestuffs and aromatic amines. IARC Monogr Eval Carcinog Risks Hum 1993;57:7-398.
33. Guidotti S, Wright WE, Peters JM. Multiple myeloma in cosmetologists. Am J Ind Med 1982;3:169-71.
34. Spinelli JJ, Gallagher RP, Band PR, et al. Multiple myeloma, leukemia, and cancer of the ovary in cosmetologists and hairdressers. Am J Ind Med 1984;6:97-102.
35. De Roos AJ, Stewart PA, Linet MS, et al. Occupation and the risk of adult glioma in the United States. Cancer Causes Control 2003;14:139-50.
36. Rajaraman P, De Roos AJ, Stewart PA, et al. Occupation and risk of meningioma and acoustic neuroma in the United States. Am J Ind Med 2004;45:395-407.
37. Efird JT, Holly EA, Cordier S, et al. Beauty product-related exposures and childhood brain tumors in seven countries: results from the SEARCH International Brain Tumor Study. J Neurooncol 2005;72:133-47.
38. Holly EA, Bracci PM, Hong MK, et al. West Coast study of childhood brain tumours and maternal use of hair-colouring products. Paediatr Perinat Epidemiol 2002;16:226-35.
39. Nohynek GJ, Fautz R, Benech-Kieffer F, et al. Toxicity and human health risk of hair dyes. Food Chem Toxicol 2004;42:517-43.
40. Inskip PD, Hatch EE, Stewart PA, et al. Study design for a case-control investigation of cellular telephones and other risk factors for brain tumors in adults. Radiat Prot Dosim 1999;86:45-52.
41. Inskip PD, Tarone RE, Hatch EE, et al. Cellular-telephone use and brain tumors. N Engl J Med 2001;344:79-86.
42. World Health Organization. International classification of diseases for oncology. Second Edition. Geneva, Switzerland: World Health Organization, 1990.
43. Dressler WE. Concentrations of p-phenylenediamine and other dye intermediates by hair color. Presented at the Epidemiology-Toxicology Workshop on Hair Dyes, Baltimore, Maryland, October 12-13, 2004.
44. Heineman EF, Ward MH, McComb RD, et al. Hair dyes and risk of glioma among Nebraska women. Cancer Causes Control 2005;16:857-64.
45. Berleur MP, Cordier S. The role of chemical, physical, or viral exposures and health factors in neurocarcinogenesis: implications for epidemiologic studies of brain tumors. Cancer Causes Control 1995;6:240-56.
46. Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-Oncol 2002;4:278-99.
47. Inskip PD, Linet MS, Heineman EF. Etiology of brain tumors in adults. Epidemiol Rev 1995;17:382-414.
48. Tuomanen E. Breaching the blood-brain barrier. Sci Am 1993;268:80-4.
49. Tuomanen E. Susceptibility to infection and age-related changes in the blood-brain barrier. Neurobiol Aging 1994;15:757-8.
50. Van Neste D, Tobin DJ. Hair cycle and hair pigmentation: dynamic interactions and changes associated with aging. Micron 2004;35:193-200.
51. Commo S, Gaillard O, Bernard BA. Human hair greying is linked to a specific depletion of hair follicle melanocytes affecting both the bulb and the outer root sheath. Br J Dermatol 2004;150:435-43.
52. Nishimura EK, Granter SR, Fisher DE. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science 2005;307:720-4.
53. Zahm SH, Blair A, Fraumeni JF Jr. Hair coloring products: safe or still suspect? J Natl Cancer Inst 1994;86:941-3.
54. Johns LE, Houlston RS. N-acetyl transferase-2 and bladder cancer risk: a meta-analysis. Environ Mol Mutagen 2000;36:221-7.